A new approach to treating pancreatic cancer using ‘educated killer cells’ has shown promise, according to a new study by UNSW medical researchers. Researchers from UNSW Sydney and the California Institute of Biomedical Research (CALIBR) have demonstrated the success of a new, cell-based immunotherapy for pancreatic cancer. The treatment led to mice being completely cancer-free,...
Post
Researchers use AI to treat metastatic cancer patient
September 4, 2018, National University of Singapore A transnational research team led by the National University of Singapore (NUS) has harnessed CURATE.AI, a powerful artificial intelligence (AI) platform, to treat a patient with advanced cancer, completely halting disease progression. This new development represents a big step forward in personalized medicine. Professor Dean Ho (left) and Mr...
Post
Achilles heel of anaplastic large-cell lymphoma (ALCL) cells identified
Anaplastic large-cell lymphomas (ALCL) are rare cancers of the white blood cells. New research from the international ERIA consortium, led by scientists in Vienna, has now shown that the same signaling pathway is essential to the growth of cancer cells in various forms of ALCL: TYK2 (tyrosine kinase 2, an important component of the immune system) prevents...
Post
Reprogramming skin cells to repair themselves
Skin grafts are risky in an increasing number of patients, partly due to rising rates of diabetes This method by the Salk Institute could avoid dangerous outcomes UC San Diego biology professor Juan Carlos Izpisua Belmonte explains his work People with severe burns, bedsores or chronic diseases such as diabetes are at risk for developing...
Post
A new theory for phantom limb pain points the way to more effective treatment
CHALMERS UNIVERSITY OF TECHNOLOGY Dr Max Ortiz Catalan of Chalmers University of Technology, Sweden, has developed a new theory for the origin of the mysterious condition, ‘phantom limb pain’. Published in the journal Frontiers in Neurology, his hypothesis builds upon his previous work on a revolutionary treatment for the condition, that uses machine learning and...
Post
How olive oil and sleep could stave off heart attacks and strokes: New study examines plasma protein’s role
Apolipoprotein A-IV linked with thrombosis in new study ST. MICHAEL’S HOSPITAL TORONTO, September 6, 2018 – Foods high in unsaturated fats may protect against cardiovascular disease, and new research published today in Nature Communicationshas uncovered why. IMAGE: NEW RESEARCH FROM DR. HEYU NI, PLATFORM DIRECTOR FOR HEMATOLOGY, CANCER AND IMMUNOLOGICAL DISEASES AT THE KEENAN RESEARCH CENTRE FOR BIOMEDICAL SCIENCE (KRCBS) OF ST. MICHAEL’S...
Post
New biomarker panel could accelerate autism diagnoses
About 17 percent of kids with autism identified with metabolic blood test UNIVERSITY OF CALIFORNIA – DAVIS HEALTH SYSTEM Investigators at the UC Davis MIND Institute and NeuroPointDX, a division of Stemina Biomarker Discovery, have identified a group of blood metabolites that could help detect some children with autism spectrum disorder (ASD). Part of the...
Post
Scientists identify weak point in deadly eye melanoma
Plant compound shuts down tumor growth WASHINGTON UNIVERSITY SCHOOL OF MEDICINE A natural plant compound exploits a newly identified Achilles’ heel in a cancer of the eye, uveal melanoma. In human cancer cells growing in the lab, the compound shuts down the overactive signaling that drives uveal melanoma cell growth, according to researchers at Washington University School...
Post
Spreading the word: Noninvasive brain stimulation may soon reach more aphasia patients
MEDICAL UNIVERSITY OF SOUTH CAROLINA Sometimes in research, a smaller finding can open the door to big possibilities. Neuroscientists at the University of South Carolina (USC) and the Medical University of South Carolina (MUSC) have collaborated on a study in the field of aphasia that has successfully paved the way for a large clinical trial....
Post
Antibacterial polymers
Surprising antibacterial activity and selectivity of hydrophilic phosphonium polymers WILEY Artificial polymers, like antibiotic peptides, need both hydrophobic and hydrophilic domains in their molecular structure to exert antibacterial activity. Now, researchers from Canada have synthesized a phosphonium polymer that challenges this view. As outlined in the journal Angewandte Chemie, their polymer salt contained no hydrophobic alkyl chains but...